Breaking News, Financial News

Cambrex

Revenues slipped due to several factors

Cambrex 2Q10

2Q Revenues: $58.2 million (-2%)

2Q Earnings: $4.8 million (-13%)

YTD Revenues: $114.3 million (-5%)

YTD Earnings: $6.4 million (-37%)

Comments: The drop in revenues was blamed on reduced demand for some large products, a supply chain disruption at a customer’s facility, lower pricing on generic APIs, and a renegotiated contract extension for drug delivery products, resulting in lower pricing. Increased sales volume for controlled substances and generic APIs helped offset some of the drop.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters